Prelude Capital Management, LLC Outset Medical, Inc. Transaction History

Prelude Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$10.52 - $20.68 $215,260 - $423,154	20,462 New	20,462 $222,000
Q4 2022 Feb 14, 2023	BUY	$12.36 - $26.41 $116,468 - $248,861	9,423 New	9,423 $243,000
Q1 2022 May 16, 2022	SELL	$34.22 - $47.24 $273,760 - $377,920	-8,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$36.86 - $54.98 $110,580 - $164,940	3,000 Added 60.0%	8,000 $396,000
Q2 2021 Aug 16, 2021	BUY	$41.49 - $59.92 $207,450 - $299,600	5,000 New	5,000 $250,000

122

41M

63.4K

32.1K

Ticker OM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 48,007,300
Market Cap $181M
Description
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.